HEADER TRANSFERASE/TRANSFERASE INHIBITOR 26-JUL-14 4QYY TITLE DISCOVERY OF NOVEL, DUAL MECHANISM ERK INHIBITORS BY AFFINITY TITLE 2 SELECTION SCREENING OF AN INACTIVE KINASE STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 1, MAPK 1, ERT1, EXTRACELLULAR SIGNAL-REGULATED COMPND 5 KINASE 2, ERK-2, MAP KINASE ISOFORM P42, P42-MAPK, MITOGEN-ACTIVATED COMPND 6 PROTEIN KINASE 2, MAP KINASE 2, MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: BROWN RAT,RAT,RATS; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: MAPK1, ERK2, MAPK, PRKM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, MAP KINASE, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.DENG,G.W.SHIPPS,A.COOPER,J.M.ENGLISH,D.A.ANNIS,D.CARR,Y.NAN,T.WANG, AUTHOR 2 Y.H.ZHU,C.CHUANG,P.DAYANANTH,A.W.HRUZA,L.XIAO,W.JIN,P.KIRSCHMEIER, AUTHOR 3 W.T.WINDSOR,A.A.SAMATAR REVDAT 3 20-SEP-23 4QYY 1 REMARK SEQADV REVDAT 2 17-DEC-14 4QYY 1 JRNL REVDAT 1 12-NOV-14 4QYY 0 JRNL AUTH Y.DENG,G.W.SHIPPS,A.COOPER,J.M.ENGLISH,D.A.ANNIS,D.CARR, JRNL AUTH 2 Y.NAN,T.WANG,H.Y.ZHU,C.C.CHUANG,P.DAYANANTH,A.W.HRUZA, JRNL AUTH 3 L.XIAO,W.JIN,P.KIRSCHMEIER,W.T.WINDSOR,A.A.SAMATAR JRNL TITL DISCOVERY OF NOVEL, DUAL MECHANISM ERK INHIBITORS BY JRNL TITL 2 AFFINITY SELECTION SCREENING OF AN INACTIVE KINASE. JRNL REF J.MED.CHEM. V. 57 8817 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25313996 JRNL DOI 10.1021/JM500847M REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 49215 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2464 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3380 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2584 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3216 REMARK 3 BIN R VALUE (WORKING SET) : 0.2576 REMARK 3 BIN FREE R VALUE : 0.2741 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.85 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 164 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2757 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 188 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.71520 REMARK 3 B22 (A**2) : 0.10470 REMARK 3 B33 (A**2) : 1.61050 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.215 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.128 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5667 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10247 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1262 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 73 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 834 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5667 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : 3 ; 0.000 ; HARMONIC REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 367 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6315 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.63 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.17 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|13 - A|353 A|401 - A|404 A|601 - A|788 } REMARK 3 ORIGIN FOR THE GROUP (A): 52.9821 19.0412 19.4617 REMARK 3 T TENSOR REMARK 3 T11: -0.0482 T22: -0.0769 REMARK 3 T33: -0.0711 T12: 0.0106 REMARK 3 T13: -0.0041 T23: -0.0019 REMARK 3 L TENSOR REMARK 3 L11: 1.2063 L22: 0.7987 REMARK 3 L33: 0.9119 L12: -0.5050 REMARK 3 L13: -0.4974 L23: 0.0852 REMARK 3 S TENSOR REMARK 3 S11: 0.0690 S12: 0.2118 S13: -0.0808 REMARK 3 S21: -0.0470 S22: -0.0809 S23: 0.1003 REMARK 3 S31: -0.0307 S32: -0.0917 S33: 0.0119 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QYY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000086689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-04 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49215 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 29.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 18.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.60200 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1ERK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES, PH 6.4, 2.0M AMMONIUM REMARK 280 SULFATE, 5% PEG 400, 0.5% DMSO, 1% GLYEROL, 0.0005M OLOMOUCINE, REMARK 280 10 DAY SOAK WITH NEW COMPOUND, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.60100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.70450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.60100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.70450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 PRO A 9 REMARK 465 GLU A 10 REMARK 465 MET A 11 REMARK 465 VAL A 12 REMARK 465 PHE A 329 REMARK 465 ASP A 330 REMARK 465 MET A 331 REMARK 465 GLU A 332 REMARK 465 PRO A 354 REMARK 465 GLY A 355 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 291 SD MET A 291 CE -0.401 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 16 122.52 125.40 REMARK 500 ASN A 25 80.57 56.14 REMARK 500 LYS A 46 -65.18 68.41 REMARK 500 THR A 108 -169.20 -160.13 REMARK 500 ASP A 147 42.37 -152.84 REMARK 500 ASP A 165 86.57 70.00 REMARK 500 ASP A 173 68.74 -152.77 REMARK 500 ASN A 199 12.18 -164.20 REMARK 500 ILE A 254 -63.84 75.52 REMARK 500 LEU A 292 43.40 -95.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3G7 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 404 DBREF 4QYY A 1 358 UNP P63086 MK01_RAT 1 358 SEQADV 4QYY ALA A -6 UNP P63086 EXPRESSION TAG SEQADV 4QYY HIS A -5 UNP P63086 EXPRESSION TAG SEQADV 4QYY HIS A -4 UNP P63086 EXPRESSION TAG SEQADV 4QYY HIS A -3 UNP P63086 EXPRESSION TAG SEQADV 4QYY HIS A -2 UNP P63086 EXPRESSION TAG SEQADV 4QYY HIS A -1 UNP P63086 EXPRESSION TAG SEQADV 4QYY HIS A 0 UNP P63086 EXPRESSION TAG SEQRES 1 A 365 ALA HIS HIS HIS HIS HIS HIS MET ALA ALA ALA ALA ALA SEQRES 2 A 365 ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE ASP VAL SEQRES 3 A 365 GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY GLU GLY SEQRES 4 A 365 ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN LEU ASN SEQRES 5 A 365 LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO PHE GLU SEQRES 6 A 365 HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU ILE LYS SEQRES 7 A 365 ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY ILE SEQRES 8 A 365 ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN MET LYS SEQRES 9 A 365 ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR ASP LEU SEQRES 10 A 365 TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN ASP HIS SEQRES 11 A 365 ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU LYS SEQRES 12 A 365 TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP LEU LYS SEQRES 13 A 365 PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP LEU LYS SEQRES 14 A 365 ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO ASP SEQRES 15 A 365 HIS ASP HIS THR GLY PHE LEU THR GLU TYR VAL ALA THR SEQRES 16 A 365 ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SER LYS SEQRES 17 A 365 GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL GLY CYS SEQRES 18 A 365 ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE PHE PRO SEQRES 19 A 365 GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU GLY SEQRES 20 A 365 ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN CYS ILE SEQRES 21 A 365 ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER LEU PRO SEQRES 22 A 365 HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO ASN SEQRES 23 A 365 ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS MET LEU SEQRES 24 A 365 THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN ALA SEQRES 25 A 365 LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SER SEQRES 26 A 365 ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP MET SEQRES 27 A 365 GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU LEU SEQRES 28 A 365 ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY TYR ARG SEQRES 29 A 365 SER HET 3G7 A 401 34 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HETNAM 3G7 (3R)-1-{2-[4-(4-ACETYLPHENYL)PIPERAZIN-1-YL]-2- HETNAM 2 3G7 OXOETHYL}-N-(3-CHLORO-4-HYDROXYPHENYL)PYRROLIDINE-3- HETNAM 3 3G7 CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 2 3G7 C25 H29 CL N4 O4 FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 HOH *188(H2 O) HELIX 1 1 HIS A 59 PHE A 76 1 18 HELIX 2 2 LEU A 110 GLN A 117 1 8 HELIX 3 3 SER A 120 ALA A 141 1 22 HELIX 4 4 LYS A 149 SER A 151 5 3 HELIX 5 5 ASP A 173 ASP A 177 5 5 HELIX 6 6 THR A 188 ALA A 193 5 6 HELIX 7 7 PRO A 194 ASN A 199 1 6 HELIX 8 8 LYS A 205 ASN A 222 1 18 HELIX 9 9 HIS A 230 GLY A 243 1 14 HELIX 10 10 SER A 246 CYS A 252 1 7 HELIX 11 11 ASN A 255 LEU A 265 1 11 HELIX 12 12 PRO A 272 PHE A 277 1 6 HELIX 13 13 ASP A 281 LEU A 292 1 12 HELIX 14 14 GLU A 301 ALA A 307 1 7 HELIX 15 15 HIS A 308 GLU A 312 5 5 HELIX 16 16 ASP A 316 GLU A 320 5 5 HELIX 17 17 PRO A 337 ALA A 350 1 14 HELIX 18 18 ARG A 351 GLN A 353 5 3 SHEET 1 A 5 TYR A 23 GLY A 32 0 SHEET 2 A 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24 SHEET 3 A 5 ARG A 48 ILE A 54 -1 O VAL A 49 N ALA A 40 SHEET 4 A 5 VAL A 99 ASP A 104 -1 O GLN A 103 N ALA A 50 SHEET 5 A 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 B 3 THR A 108 ASP A 109 0 SHEET 2 B 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 B 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 C 2 VAL A 143 LEU A 144 0 SHEET 2 C 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 CISPEP 1 GLY A 20 PRO A 21 0 -0.36 SITE 1 AC1 15 ALA A 33 TYR A 34 ALA A 50 LYS A 52 SITE 2 AC1 15 ILE A 54 TYR A 62 GLU A 69 GLN A 103 SITE 3 AC1 15 ASP A 104 LEU A 105 MET A 106 LEU A 154 SITE 4 AC1 15 ASP A 165 GLY A 167 HOH A 766 SITE 1 AC2 6 TYR A 185 ARG A 189 ARG A 192 TYR A 231 SITE 2 AC2 6 HOH A 722 HOH A 731 SITE 1 AC3 6 ASN A 121 GLY A 180 LYS A 257 HOH A 637 SITE 2 AC3 6 HOH A 644 HOH A 708 SITE 1 AC4 3 GLN A 64 ARG A 65 LEU A 168 CRYST1 71.202 91.409 63.316 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014045 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010940 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015794 0.00000